Paying attention

Ebb & Flow

Paying attention
After noticing that TriMark Holdings was actively purchasing its shares in the secondary market, Genzyme Transgenics (GZTC) turned that demand into a financing round. "They had been buying in the open market," said CFO John Green, "and we talked to them about increasing their position and we did that by utilizing the shares we had on the shelf." The developer of transgenic proteins ended up selling 450,000

Read the full 706 word article

How to gain access

Continue reading with a
two-week free trial.